Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macaca | 1 | 2023 | 62 | 0.850 |
Why?
|
| Face | 1 | 2023 | 180 | 0.780 |
Why?
|
| Ketamine | 4 | 2023 | 214 | 0.750 |
Why?
|
| Facial Recognition | 1 | 2021 | 7 | 0.750 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 3 | 2023 | 115 | 0.490 |
Why?
|
| Anesthetics, Dissociative | 1 | 2013 | 20 | 0.420 |
Why?
|
| Faculty | 1 | 2013 | 99 | 0.390 |
Why?
|
| Electroconvulsive Therapy | 2 | 2023 | 66 | 0.350 |
Why?
|
| Cognition | 3 | 2018 | 737 | 0.340 |
Why?
|
| Blood Donors | 2 | 2020 | 62 | 0.340 |
Why?
|
| Brain Injuries | 1 | 2013 | 762 | 0.280 |
Why?
|
| Physicians | 1 | 2013 | 581 | 0.270 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1078 | 0.250 |
Why?
|
| Antidepressive Agents | 2 | 2023 | 288 | 0.210 |
Why?
|
| Photic Stimulation | 1 | 2023 | 214 | 0.200 |
Why?
|
| Brain | 3 | 2023 | 2966 | 0.190 |
Why?
|
| Hepatitis B, Chronic | 1 | 2022 | 82 | 0.190 |
Why?
|
| White Matter | 1 | 2023 | 180 | 0.180 |
Why?
|
| Hepatitis B | 1 | 2022 | 159 | 0.180 |
Why?
|
| Primates | 1 | 2021 | 81 | 0.180 |
Why?
|
| Drug Resistance, Viral | 1 | 2020 | 44 | 0.180 |
Why?
|
| Luminescent Measurements | 1 | 2019 | 57 | 0.170 |
Why?
|
| Treponema pallidum | 1 | 2019 | 49 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 216 | 0.160 |
Why?
|
| Syphilis | 1 | 2019 | 95 | 0.160 |
Why?
|
| Hepacivirus | 1 | 2020 | 241 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2021 | 632 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 810 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 383 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3549 | 0.140 |
Why?
|
| Hepatitis C | 1 | 2020 | 364 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2020 | 744 | 0.120 |
Why?
|
| Bone Transplantation | 1 | 2014 | 49 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 80 | 0.110 |
Why?
|
| Anesthetics, Intravenous | 1 | 2013 | 47 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2014 | 107 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2013 | 42 | 0.110 |
Why?
|
| Anesthetics, Inhalation | 1 | 2013 | 46 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2014 | 154 | 0.110 |
Why?
|
| Sleep Stages | 1 | 2013 | 32 | 0.110 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 38 | 0.110 |
Why?
|
| Verbal Learning | 1 | 2013 | 66 | 0.100 |
Why?
|
| Arousal | 1 | 2013 | 82 | 0.100 |
Why?
|
| Sleep Deprivation | 1 | 2013 | 50 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 926 | 0.100 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 182 | 0.100 |
Why?
|
| Animals | 3 | 2023 | 33852 | 0.100 |
Why?
|
| Impulsive Behavior | 1 | 2013 | 144 | 0.100 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 140 | 0.100 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2012 | 27 | 0.100 |
Why?
|
| Attention | 1 | 2013 | 196 | 0.100 |
Why?
|
| Methamphetamine | 1 | 2012 | 32 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 120 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 67 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 125 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1012 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 256 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 337 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2012 | 177 | 0.080 |
Why?
|
| China | 2 | 2020 | 241 | 0.080 |
Why?
|
| Humans | 14 | 2023 | 123262 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2013 | 1171 | 0.070 |
Why?
|
| Middle Aged | 4 | 2021 | 26091 | 0.060 |
Why?
|
| Female | 7 | 2023 | 65618 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1601 | 0.050 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2023 | 17 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2023 | 38 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2023 | 55 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2023 | 54 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 54 | 0.050 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2022 | 52 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 143 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 804 | 0.050 |
Why?
|
| Male | 6 | 2023 | 60334 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 136 | 0.050 |
Why?
|
| Hepatitis B virus | 1 | 2022 | 136 | 0.050 |
Why?
|
| Adult | 4 | 2018 | 29100 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2022 | 479 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 185 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 433 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 280 | 0.040 |
Why?
|
| Mothers | 1 | 2023 | 349 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 539 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2023 | 12170 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2018 | 12 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2022 | 332 | 0.040 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2020 | 193 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 400 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 694 | 0.040 |
Why?
|
| Anxiety | 1 | 2023 | 959 | 0.030 |
Why?
|
| Genotype | 1 | 2022 | 2538 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2020 | 849 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3239 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 28 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 81 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 178 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1080 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2409 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 2013 | 23 | 0.030 |
Why?
|
| Isoflurane | 1 | 2013 | 45 | 0.030 |
Why?
|
| Propofol | 1 | 2013 | 44 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1933 | 0.030 |
Why?
|
| Morphine | 1 | 2013 | 88 | 0.030 |
Why?
|
| Fentanyl | 1 | 2013 | 47 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3384 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 1230 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 235 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 8867 | 0.030 |
Why?
|
| Child | 2 | 2023 | 24256 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2013 | 358 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 239 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 141 | 0.020 |
Why?
|
| Polysomnography | 1 | 2012 | 142 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1687 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 202 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 403 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 5767 | 0.020 |
Why?
|
| Sleep | 1 | 2012 | 350 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 12376 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3666 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 13918 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1915 | 0.020 |
Why?
|
| United States | 1 | 2022 | 10654 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5056 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4298 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 19127 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 6223 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6030 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 19198 | 0.010 |
Why?
|